Page 176 - shbh24_complete
P. 176

JSE – REM                                Profile’s Stock Exchange Handbook: 2024 – Issue 3
                                                              NUMBER OF EMPLOYEES: 173
                    Remgro Ltd.                               DIRECTORS: de BruynSEN(ld ind ne),
        REM                                                    Lubbe M, MagezaNP(ind ne), Malherbe J (ne),
                                                               MoleketiPJ(ind ne), MorobeMM(ind ne),
                                                               NeethlingPJ(alt), NieuwoudtGG(ne),
                                                               Rantloane L (ind ne), Rupert A (ne),
                                                               VoslooCP(alt), Rupert J P (Chair, ne),
                                                               Robertson F (Co Dep Chair, ind ne),
                                                               Durand J J (CEO), Williams N (CFO)
                                                  Scan the QR code to  POSTALADDRESS:POBox456,Stellenbosch,7599
                                                   visit our website  EMAIL: dh@remgro.com
                                                              WEBSITE: www.remgro.com
                                                  TELEPHONE: 021-888-3000  FAX: 021-888-3399
       ISIN: ZAE000026480  SHORT: REMGRO  CODE: REM
       REG NO: 1968/006415/06  FOUNDED: 2000  LISTED: 2000  COMPANY SECRETARY: Danielle Dreyer
                                                  TRANSFER SECRETARY: Computershare Investor Services (Pty) Ltd.
        NATURE OF BUSINESS:                       SPONSOR: Rand Merchant Bank (A division of FirstRand Bank Ltd.)
        Remgro Ltd. is an investment holding company established  AUDITORS: Ernst & Young Inc.
                                                  BANKERS: First National Bank
        with effect from 1 April 2000, after the restructuring of the
        former Rembrandt Group Ltd. The Group’s interests consist  CALENDAR  Expected  Status
        mainlyofinvestmentsinconsumerproducts;financialservices;  Next Final Results  Sep 2024  Unconfirmed
        healthcare; industrial; infrastructure as well as media.  Annual General Meeting  Dec 2024  Unconfirmed
        The company’s activities are concentrated mainly on the man-  Next Interim Results  Mar 2025  Unconfirmed
        agement of investments and the provision of support rather
        than on being involved in the day-to-day management of  CAPITAL STRUCTURE  AUTHORISED  ISSUED
        business units of investees.              REM  Ords no par     1 000 000 000  529 217 007
        Subsidiaries not wholly owned include listed companies with  DISTRIBUTIONS [ZARc]
        independent boards of directors on which this company has  Ords no par  Ldt  Pay  Amt
                                                  Interim No 47     16 Apr 24  22 Apr 24  80.00
        non-executive representation. Non-subsidiary investments  Final No 46  7 Nov 23  13 Nov 23  160.00
        comprisebothlistedandunlistedcompaniesnotcontrolledby  Interim No 45  18 Apr 23  24 Apr 23  80.00
        this company and which are mostly associated companies due  Final No 44  8 Nov 22  14 Nov 22  100.00
        to significant influence and board representation.  LIQUIDITY: Jun24 Avg 6m shares p.w., R863.7m(59.6% p.a.)
       SECTOR: Fins—FinServcs—InvBnkng&BrokerServcs— DiversFinServcs  GENF  40 Week MA  REMGRO
       CONTROLLED BY: Rupert Beleggings (Pty) Ltd.
       MAJOR ORDINARY SHAREHOLDERS as at 25 Jan 2024
         Public Investment Commissioner   16.62%                                       14664
         Ninety One SA (Pty) Ltd.          5.10%
       NOTES:Remgrounbundledsharesintheapportionmentratioof0.7255039                   13081
        unbundled shares on 8 June 2020.
       FINANCIAL STATISTICS                                                            11497
       (R million)  Dec 23  Jun 23  Jun 22  Jun 21  Jun 20                             9914
                   Interim  Final Final(rst)  Final  Final
       Sales        25 414  48 151  41 876  65 803  54 732                             8330
                                                     2019  |  2020  |  2021  |  2022  |  2023  |
       Op Inc        1 506  2 335  2 057  4 449  1 545
       NetIntPd(Rcvd)  113  17   499  1 102  1 014  Recent Announcements
       Tax            597  832   757  1 135  452  Friday, 14 June 2024: The Remgro Board approved the merger of
       Minority Int   719  1 196  1 840  1 505  - 63  the Remgro Strategic ESG Committee and the Remgro Social
       Att Inc      - 2 394  9 624  13 139  3 550  6 646
       TotCompIncLoss  - 4 058  21 618  13 033  2 543  3 167  and Ethics Committee with effect from 1 July 2024 to form the
                                                   Remgro Social and Ethics and Sustainability Committee.
       Hline Erngs-CO  2 117  6 642  5 816  2 885  1 737
       Fixed Ass    10 525  10 230  17 968  16 889  16 954  Friday, 05 April 2024: The board of directors of Remgro has
       Inv in Assoc  69 154  76 445  50 771  50 207  50 991  approved the appointmentofCarel Petrus FrancoisVoslooas an
       Inv & Loans  23 017  22 747  21 047  14 702  12 995  alternate executive director to Jannie Durand. He will also be
       Def Tax Asset  208  176   219   208  190    appointed as a member of the Remgro ManagementBoard, both
       Tot Curr Ass  26 049  23 707  44 478  37 381  43 640  appointments with effect from 5 April 2024.
       Ord SH Int  109 587  115 920  98 443  88 059  86 773  Remgro interim results December 2023 - Tuesday, 19 March 2024:
       Minority Int  7 320  6 521  17 437  15 517  14 670  Continuing operations
       LT Liab      12 059  11 787  21 128  20 103  23 139  Revenue for the interim period grew to R25.4 billion (2022:
       Tot Curr Liab  10 984  12 740  19 295  17 087  22 517  R24.2 billion) while trading profit went up to R1.5 billion
       PER SHARE STATISTICS (cents per share)      (2022: R1 billion). Net loss for the interim period was reported
       EPS (ZARc)  - 432.00 1 710.00 2 328.00  615.77 1 152.94  at R2.5 billion (2022: profit of R3.6 billion). In addition,
       HEPS-C (ZARc)  382.00 1 180.00 1 031.00  500.42  301.37  headline earnings per share came in lower at 382 cents per share
       Pct chng p.a.  - 35.3  14.5  106.0  66.0  - 68.7  (2022: 542 cents per share).
       Tr 5yr av grwth %  -  22.6  20.0  3.8  - 15.0  Dividend declaration
       DPS (ZARc)    80.00  240.00  150.00  88.20  201.87  Notice was given that an interim gross dividend of 80 cents
       Pct chng p.a.   -   60.0  70.1  - 56.3  - 49.7  (2022: 80 cents) per share has been declared out of income
       Tr 5yr av grwth %  -  6.0  - 4.5  - 17.0  - 4.2  reserves in respect of both the ordinary shares of no par value
       NAV PS (ZARc)  19 284.18 20 751.00 17 452.00 15 275.16 15 052.69  and the unlisted B ordinary shares of no par value, for the six
       3 Yr Beta     0.54  0.52  0.84  0.92  0.92  months ended 31 December 2023.
       Price High   16 401  14 840  15 176  12 251  14 374  Friday, 15 March 2024: Given that Mediclinic Group Ltd.
       Price Low    13 754  12 207  10 513  8 128  7 220  (“Mediclinic” or “Group”) is no longer listed due to the
       Price Prd End  16 248  14 705  12 732  11 231  9 791  acquisition by Manta Bidco Ltd. (a consortium made up of
       RATIOS                                      Remgro and MSC Mediterranean Shipping Company SA) of the
       Ret on SH Fnd  - 2.87  8.84  12.93  4.88  6.49  entire issued share capital of Mediclinic, there is no regulatory
       Ret On Tot Ass  1.92  4.83  9.51  4.44  - 1.35  requirement for Mediclinic to release financial results.
       Oper Pft Mgn  5.93  4.85  4.91  6.76  2.82  However,consideringthesignificantcontributionbyMediclinic
       D:E           0.13  0.15  0.21  0.23  0.33  to Remgro’s results and intrinsic net asset value, Remgro
       Int Cover    - 10.65  191.53  6.61  5.15  1.54
       Current Ratio  2.37  1.86  2.31  2.19  1.94  believes that it is appropriate to release a summary of
       Div Cover     - 5.40  7.13  15.52  6.98  5.71  Mediclinic’s 2024 half-year financial results and an outlook for
                                                   the year ending 31 March 2024.
                                               174
   171   172   173   174   175   176   177   178   179   180   181